宫颈上皮内瘤变患者LEEP术后复发的危险因素分析

doi:10.3969/j.issn.1671-7171.2018.10.069

摘要
图/表
参考文献(10)
相关文章 (15)

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨宫颈上皮内瘤变(CIN)患者宫颈环形电切术(LEEP)术后复发的危险因素。【方法】选取2012年1月至2017年6月在本院诊治的CIN 患者300例,根据LEEP术后是否复发分为复发组和未复发组,单因素和Logistic回归分析CIN患者LEEP术后复发的危险因素。【结果】复发组和未复发组的孕次、产次、绝经情况、治疗前后高危HPV感染状态、是否吸烟、颈管累及、累及象限情况比较差异均具有统计学意义(P<0.05);Logistic回归分析显示,LEEP术后复发的危险因素为绝经情况、手术前后HPV感染、象限累及、病变程度以及颈管累及情况。【结论】CIN患者LEEP手术前后高危HPV感染、绝经情况、象限累及情况、颈管累及和病变程度为CIN患者复发的独立危险因素。因此,在LEEP术后对绝经、HPV感染、象限累及、颈管累及的女性应密切观察并采取相应干预措施,以减少术后复发带来的危险。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	司马琴

关键词 ：环扎术, 宫颈/副作用, 宫颈上皮内瘤样病变

收稿日期: 2018-03-09

PACS:

R713.4

引用本文:

司马琴. 宫颈上皮内瘤变患者LEEP术后复发的危险因素分析[J]. 医学临床研究, 2018, 35(10): 2058-2060.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2018.10.069 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2018/V35/I10/2058

[1] 费晓璐, 杨秀凤, 刘榕娟,等. 宫颈上皮内瘤变CINⅢ行CKC术后个体化治疗的效果分析[J].湖南师范大学学报(医学版), 2017, 14(1):80-83.
[2] Massad LS, Einstein MH, Huh WK,et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors[J].Obstet Gynecol,2013,121(4):829-846.
[3] Kyrgiou M, Mitra A, Paraskevaidis E. Fertility and early pregnancy outcomes following conservative treatment for cervical intraepithelial neoplasia and early cervical cancer[J].JAMA Oncol,2016, 2(11): 1496-1498.
[4] Carlander C,Marrone G, Br nnstr m J, et al.Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study[J].BJOG,2017 ,124(11):1680-1687.
[5] Juckes J, Patil V. Re: Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study[J].BJOG,2017, 124(11):1794-1795.
[6] Herfs M, Somja J, Howitt BE, et al. Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction[J].Int J Cancer,2015, 136(5):1043-1052.
[7] Bogani G,Taverna F,Lombardo C, et al. Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology[J].Int J Gynaecol Obstet,2017, 138(1):62-68.
[8] Mo LZ, Song HL, Wang JL, et al. Pap smear combined with HPV testing: a reasonable tool for women with high-grade cervical intraepithelial neoplasia treated by LEEP[J].Asian Pac J Cancer Prev,2015, 16(10):4297-4302.
[9] Ofosu A. Clostridium difficile infection: a review of current and emerging therapies[J].Ann Gastroenterol,2016, 29(2):147-154.
[10] Katki HA, Schiffman M, Castle PE, et al. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management[J].J Low Genit Tract Dis,2013, 17(1):78-84.